Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michaela Schwarz

Showing results (21-30 of 34) with videos related to

Pageof 4
Sort By:
Cancer|June 24, 2010
Activity and tolerability of nilotinib: a retrospective multicenter analysis of chronic myeloid leukemia patients who are imatinib resistant or intolerantMaya Koren-Michowitz, Philipp le Coutre, Justus Duyster, et al.
Thyroid : Official Journal of the American Thyroid Association|October 9, 2010
Thyroid dysfunction caused by second-generation tyrosine kinase inhibitors in Philadelphia chromosome-positive chronic myeloid leukemiaTheo D Kim, Michaela Schwarz, Hendrik Nogai, et al.
Haematologica|January 25, 2012
Clinical cardiac safety profile of nilotinibTheo D Kim, Philipp le Coutre, Michaela Schwarz, et al.
American Journal of Hematology|July 25, 2003
Imatinib in Philadelphia chromosome-positive chronic phase CML patients: molecular and cytogenetic response rates and prediction of clinical outcomePhilipp Le Coutre, Karl-Anton Kreuzer, Il-Kang Na, et al.
Journal of Geriatric Oncology|November 23, 2020
Clinical outcome of older adults with acute myeloid Leukemia: An analysis of a large tertiary referral Center over two decadesJana Ihlow, Sophia Gross, Nina Rosa Neuendorff, et al.
Blood Cells, Molecules & Diseases|May 4, 2002
Determination of alpha-1 acid glycoprotein in patients with Ph+ chronic myeloid leukemia during the first 13 weeks of therapy with STI571Philipp le Coutre, Karl-Anton Kreuzer, Il-Kang Na, et al.
British Journal of Haematology|August 4, 2020
Androgen derivatives improve blood counts and elongate telomere length in adult cryptic dyskeratosis congenitaMartin Kirschner, Margherita Vieri, Kim Kricheldorf, et al.
Haematologica|November 11, 2021
Acute myeloid leukemia: negative prognostic impact of early blast persistence can be in part overcome by a later remission prior to post-induction therapyJana Ihlow, Sophia Gross, Leonie Busack, et al.
Life Sciences|October 18, 2019
Oral gallic acid improves metabolic profile by modulating SIRT1 expression in obese mice brown adipose tissue: A molecular and bioinformatic approachAlanna Fernandes Paraíso, Jaciara Neves Sousa, João Marcus Oliveira Andrade, et al.
Blood Cancer Journal|September 16, 2024
Therapy-related AML: long-term outcome in a large cohort of AML-patients with intensive and non-intensive therapySophia Gross, Jana Ihlow, Leonie Busack, et al.
Pageof 4

Showing results (21-30 of 34) with videos related to

Sort By:
Pageof 4
Cancer|June 24, 2010
Activity and tolerability of nilotinib: a retrospective multicenter analysis of chronic myeloid leukemia patients who are imatinib resistant or intolerantMaya Koren-Michowitz, Philipp le Coutre, Justus Duyster, et al.
Thyroid : Official Journal of the American Thyroid Association|October 9, 2010
Thyroid dysfunction caused by second-generation tyrosine kinase inhibitors in Philadelphia chromosome-positive chronic myeloid leukemiaTheo D Kim, Michaela Schwarz, Hendrik Nogai, et al.
Haematologica|January 25, 2012
Clinical cardiac safety profile of nilotinibTheo D Kim, Philipp le Coutre, Michaela Schwarz, et al.
American Journal of Hematology|July 25, 2003
Imatinib in Philadelphia chromosome-positive chronic phase CML patients: molecular and cytogenetic response rates and prediction of clinical outcomePhilipp Le Coutre, Karl-Anton Kreuzer, Il-Kang Na, et al.
Journal of Geriatric Oncology|November 23, 2020
Clinical outcome of older adults with acute myeloid Leukemia: An analysis of a large tertiary referral Center over two decadesJana Ihlow, Sophia Gross, Nina Rosa Neuendorff, et al.
Blood Cells, Molecules & Diseases|May 4, 2002
Determination of alpha-1 acid glycoprotein in patients with Ph+ chronic myeloid leukemia during the first 13 weeks of therapy with STI571Philipp le Coutre, Karl-Anton Kreuzer, Il-Kang Na, et al.
British Journal of Haematology|August 4, 2020
Androgen derivatives improve blood counts and elongate telomere length in adult cryptic dyskeratosis congenitaMartin Kirschner, Margherita Vieri, Kim Kricheldorf, et al.
Haematologica|November 11, 2021
Acute myeloid leukemia: negative prognostic impact of early blast persistence can be in part overcome by a later remission prior to post-induction therapyJana Ihlow, Sophia Gross, Leonie Busack, et al.
Life Sciences|October 18, 2019
Oral gallic acid improves metabolic profile by modulating SIRT1 expression in obese mice brown adipose tissue: A molecular and bioinformatic approachAlanna Fernandes Paraíso, Jaciara Neves Sousa, João Marcus Oliveira Andrade, et al.
Blood Cancer Journal|September 16, 2024
Therapy-related AML: long-term outcome in a large cohort of AML-patients with intensive and non-intensive therapySophia Gross, Jana Ihlow, Leonie Busack, et al.
Pageof 4